06:47 AM EDT, 07/31/2024 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) reported Fiscal Q1 earnings Wednesday of 59.94 yen ($0.40) per diluted share, up from 57.12 yen a year earlier.

Four analysts polled by Capital IQ expected 40.40 yen.

Revenue for the quarter ended June 30 was 1.208 trillion yen, up from 1.059 trillion yen a year earlier.

Analysts surveyed by Capital IQ expected 1.081 trillion yen.

The company said it has reaffirmed its fiscal 2024 diluted core earnings decline of mid-10s%. It also reiterated its core revenue outlook for the fiscal year, which is flat to slightly declining.

Shares of the company were up more than 4% in recent Wednesday premarket activity.

Price: 14.28, Change: +0.63, Percent Change: +4.62